 Sunny Linnebur
Concepts (321)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Geriatric Nursing | 4 | 2020 | 17 | 2.510 |
Why?
| | Geriatrics | 4 | 2019 | 68 | 1.720 |
Why?
| | Health Services for the Aged | 6 | 2018 | 71 | 1.330 |
Why?
| | Practice Guidelines as Topic | 7 | 2020 | 1440 | 1.290 |
Why?
| | Polypharmacy | 6 | 2023 | 75 | 1.050 |
Why?
| | Nursing Homes | 7 | 2022 | 130 | 1.030 |
Why?
| | Anticoagulants | 3 | 2018 | 559 | 0.940 |
Why?
| | Prescription Drugs | 3 | 2012 | 113 | 0.850 |
Why?
| | Pharmacists | 8 | 2021 | 238 | 0.830 |
Why?
| | Aged, 80 and over | 27 | 2020 | 6561 | 0.790 |
Why?
| | Aging | 4 | 2020 | 1670 | 0.780 |
Why?
| | Aged | 38 | 2021 | 19657 | 0.760 |
Why?
| | Vitamin D Deficiency | 4 | 2012 | 162 | 0.740 |
Why?
| | Muscular Diseases | 1 | 2020 | 107 | 0.700 |
Why?
| | Bone Diseases | 1 | 2020 | 59 | 0.690 |
Why?
| | Vitamin D | 5 | 2016 | 354 | 0.690 |
Why?
| | Hyponatremia | 2 | 2016 | 42 | 0.670 |
Why?
| | Societies, Medical | 2 | 2019 | 703 | 0.670 |
Why?
| | Medication Therapy Management | 3 | 2023 | 72 | 0.650 |
Why?
| | Vitamin K | 1 | 2018 | 44 | 0.630 |
Why?
| | Automobile Driving | 1 | 2019 | 128 | 0.620 |
Why?
| | Safety | 1 | 2019 | 304 | 0.610 |
Why?
| | Warfarin | 2 | 2009 | 139 | 0.610 |
Why?
| | Education, Pharmacy | 4 | 2017 | 130 | 0.610 |
Why?
| | Interprofessional Relations | 1 | 2019 | 261 | 0.590 |
Why?
| | Osteoporosis | 2 | 2010 | 229 | 0.570 |
Why?
| | Self Report | 2 | 2017 | 699 | 0.560 |
Why?
| | Bupropion | 1 | 2016 | 38 | 0.550 |
Why?
| | Chemical and Drug Induced Liver Injury | 2 | 2010 | 136 | 0.550 |
Why?
| | Humans | 68 | 2023 | 118974 | 0.510 |
Why?
| | Internet | 1 | 2019 | 633 | 0.500 |
Why?
| | Curriculum | 4 | 2019 | 910 | 0.500 |
Why?
| | Antidepressive Agents | 1 | 2016 | 189 | 0.490 |
Why?
| | Health Literacy | 1 | 2016 | 169 | 0.490 |
Why?
| | Health Status | 1 | 2019 | 726 | 0.480 |
Why?
| | Health Personnel | 2 | 2019 | 588 | 0.480 |
Why?
| | Drug Therapy | 3 | 2017 | 76 | 0.480 |
Why?
| | Vitamins | 3 | 2016 | 158 | 0.480 |
Why?
| | Long-Term Care | 3 | 2022 | 74 | 0.460 |
Why?
| | Delivery of Health Care | 1 | 2020 | 867 | 0.440 |
Why?
| | Urinary Retention | 1 | 2012 | 19 | 0.430 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 992 | 0.430 |
Why?
| | Cross Infection | 2 | 2011 | 205 | 0.430 |
Why?
| | Cholinergic Antagonists | 1 | 2012 | 28 | 0.430 |
Why?
| | Prostatic Hyperplasia | 1 | 2012 | 38 | 0.420 |
Why?
| | Antihypertensive Agents | 1 | 2015 | 437 | 0.420 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2012 | 64 | 0.420 |
Why?
| | Pragmatic Clinical Trials as Topic | 2 | 2022 | 49 | 0.420 |
Why?
| | Drug Approval | 1 | 2012 | 77 | 0.410 |
Why?
| | Pharmacy Service, Hospital | 2 | 2019 | 86 | 0.410 |
Why?
| | Physicians | 2 | 2020 | 794 | 0.410 |
Why?
| | Health Communication | 1 | 2012 | 44 | 0.410 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2012 | 47 | 0.400 |
Why?
| | Students, Pharmacy | 3 | 2017 | 99 | 0.390 |
Why?
| | Grifola | 1 | 2009 | 1 | 0.370 |
Why?
| | Herb-Drug Interactions | 1 | 2009 | 3 | 0.370 |
Why?
| | International Normalized Ratio | 1 | 2009 | 45 | 0.360 |
Why?
| | Central Nervous System Agents | 1 | 2009 | 6 | 0.360 |
Why?
| | Depression | 3 | 2018 | 1132 | 0.350 |
Why?
| | Renal Insufficiency | 2 | 2016 | 150 | 0.340 |
Why?
| | Pneumonia | 2 | 2011 | 592 | 0.340 |
Why?
| | Central Nervous System Diseases | 1 | 2009 | 64 | 0.340 |
Why?
| | Patient Education as Topic | 3 | 2012 | 699 | 0.340 |
Why?
| | Fractures, Bone | 3 | 2016 | 380 | 0.340 |
Why?
| | Blood Pressure | 1 | 2015 | 1664 | 0.330 |
Why?
| | Pain | 4 | 2018 | 735 | 0.330 |
Why?
| | Drug Monitoring | 1 | 2010 | 187 | 0.330 |
Why?
| | Male | 31 | 2020 | 57801 | 0.330 |
Why?
| | Educational Measurement | 4 | 2017 | 289 | 0.310 |
Why?
| | Drug Interactions | 4 | 2018 | 352 | 0.310 |
Why?
| | Female | 32 | 2020 | 61565 | 0.300 |
Why?
| | Faculty, Dental | 1 | 2007 | 8 | 0.300 |
Why?
| | Dental Care for Chronically Ill | 1 | 2007 | 11 | 0.300 |
Why?
| | Bone and Bones | 1 | 2010 | 289 | 0.300 |
Why?
| | Education, Dental | 1 | 2007 | 24 | 0.290 |
Why?
| | Erectile Dysfunction | 1 | 2006 | 37 | 0.290 |
Why?
| | Hypertension | 1 | 2015 | 1203 | 0.290 |
Why?
| | Dietary Supplements | 1 | 2010 | 467 | 0.280 |
Why?
| | Testis | 1 | 2007 | 144 | 0.280 |
Why?
| | Urinary Tract Infections | 2 | 2019 | 136 | 0.280 |
Why?
| | Cognitive Dysfunction | 2 | 2021 | 301 | 0.270 |
Why?
| | Cholinesterase Inhibitors | 1 | 2005 | 26 | 0.260 |
Why?
| | Community Pharmacy Services | 1 | 2005 | 46 | 0.260 |
Why?
| | Patient Advocacy | 1 | 2005 | 66 | 0.260 |
Why?
| | Diphosphonates | 1 | 2004 | 50 | 0.250 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 304 | 0.250 |
Why?
| | United States | 8 | 2020 | 12555 | 0.250 |
Why?
| | Nitrofurantoin | 1 | 2004 | 7 | 0.240 |
Why?
| | Fluconazole | 1 | 2004 | 16 | 0.240 |
Why?
| | Cholecalciferol | 2 | 2016 | 51 | 0.230 |
Why?
| | Research Design | 1 | 2009 | 969 | 0.230 |
Why?
| | Antifungal Agents | 1 | 2004 | 134 | 0.230 |
Why?
| | Chronic Disease | 4 | 2019 | 1636 | 0.230 |
Why?
| | Smoking Cessation | 1 | 2006 | 360 | 0.220 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 387 | 0.220 |
Why?
| | Cyclohexanols | 1 | 2002 | 10 | 0.220 |
Why?
| | Colorado | 8 | 2018 | 4196 | 0.210 |
Why?
| | Professional Role | 4 | 2018 | 153 | 0.210 |
Why?
| | Age Factors | 5 | 2015 | 2995 | 0.210 |
Why?
| | Vaginal Diseases | 1 | 2002 | 17 | 0.210 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2002 | 37 | 0.210 |
Why?
| | Anti-Bacterial Agents | 1 | 2011 | 1510 | 0.210 |
Why?
| | Research | 1 | 2005 | 411 | 0.210 |
Why?
| | Nonprescription Drugs | 2 | 2016 | 67 | 0.210 |
Why?
| | Prevalence | 4 | 2017 | 2326 | 0.210 |
Why?
| | Administration, Oral | 3 | 2018 | 756 | 0.200 |
Why?
| | Middle Aged | 13 | 2020 | 27617 | 0.200 |
Why?
| | United States Food and Drug Administration | 2 | 2012 | 175 | 0.200 |
Why?
| | Ergocalciferols | 2 | 2012 | 12 | 0.200 |
Why?
| | Medication Adherence | 3 | 2017 | 556 | 0.190 |
Why?
| | Self Care | 2 | 2014 | 357 | 0.180 |
Why?
| | Retrospective Studies | 13 | 2021 | 12978 | 0.180 |
Why?
| | Methenamine | 1 | 2019 | 5 | 0.180 |
Why?
| | Anti-Infective Agents, Urinary | 1 | 2019 | 14 | 0.180 |
Why?
| | Alzheimer Disease | 1 | 2005 | 513 | 0.170 |
Why?
| | Diet | 1 | 2007 | 1153 | 0.170 |
Why?
| | Education, Continuing | 1 | 2019 | 40 | 0.170 |
Why?
| | Sexism | 1 | 2019 | 45 | 0.170 |
Why?
| | Patients | 2 | 2011 | 175 | 0.170 |
Why?
| | Smoking | 1 | 2006 | 1487 | 0.170 |
Why?
| | Physicians, Women | 1 | 2019 | 53 | 0.170 |
Why?
| | Pharmacy | 1 | 2019 | 30 | 0.170 |
Why?
| | Recreation | 1 | 2018 | 26 | 0.160 |
Why?
| | Transitional Care | 1 | 2019 | 38 | 0.160 |
Why?
| | Melatonin | 1 | 2019 | 109 | 0.160 |
Why?
| | Patient Transfer | 1 | 2020 | 143 | 0.160 |
Why?
| | Proton Pump Inhibitors | 1 | 2019 | 98 | 0.160 |
Why?
| | Drug Therapy, Combination | 2 | 2015 | 965 | 0.160 |
Why?
| | Drug Prescriptions | 2 | 2010 | 248 | 0.160 |
Why?
| | Hemorrhage | 1 | 2002 | 623 | 0.160 |
Why?
| | Independent Living | 1 | 2018 | 86 | 0.160 |
Why?
| | Medication Reconciliation | 2 | 2019 | 25 | 0.150 |
Why?
| | Education, Pharmacy, Graduate | 1 | 2017 | 21 | 0.150 |
Why?
| | Problem-Based Learning | 2 | 2017 | 82 | 0.150 |
Why?
| | Lung Diseases | 1 | 2004 | 718 | 0.150 |
Why?
| | Schools, Pharmacy | 1 | 2017 | 52 | 0.150 |
Why?
| | Health Education | 2 | 2016 | 318 | 0.150 |
Why?
| | Guideline Adherence | 2 | 2011 | 523 | 0.140 |
Why?
| | Refuse Disposal | 1 | 2016 | 2 | 0.140 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 218 | 0.140 |
Why?
| | Cohort Studies | 3 | 2015 | 5116 | 0.140 |
Why?
| | Leadership | 1 | 2019 | 311 | 0.140 |
Why?
| | Patient-Centered Care | 2 | 2023 | 497 | 0.140 |
Why?
| | Ibuprofen | 1 | 2016 | 76 | 0.140 |
Why?
| | Hypoglycemic Agents | 2 | 2014 | 1032 | 0.140 |
Why?
| | Dementia | 1 | 2018 | 208 | 0.140 |
Why?
| | Sleep Wake Disorders | 1 | 2019 | 241 | 0.140 |
Why?
| | Marijuana Use | 1 | 2018 | 157 | 0.130 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1129 | 0.130 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2015 | 37 | 0.130 |
Why?
| | Sodium | 1 | 2016 | 200 | 0.130 |
Why?
| | Kansas | 2 | 2011 | 28 | 0.130 |
Why?
| | Child Health | 1 | 2016 | 137 | 0.130 |
Why?
| | Faculty, Medical | 1 | 2017 | 252 | 0.130 |
Why?
| | Missouri | 2 | 2011 | 63 | 0.130 |
Why?
| | Ambulatory Care | 3 | 2008 | 482 | 0.120 |
Why?
| | Patient Care Team | 2 | 2011 | 521 | 0.120 |
Why?
| | Blood Glucose | 2 | 2014 | 1939 | 0.120 |
Why?
| | Cognition Disorders | 1 | 2018 | 529 | 0.120 |
Why?
| | Pharmaceutical Preparations | 1 | 2016 | 167 | 0.120 |
Why?
| | Creatinine | 2 | 2007 | 491 | 0.120 |
Why?
| | Priapism | 1 | 2013 | 9 | 0.120 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2013 | 31 | 0.120 |
Why?
| | Atrial Fibrillation | 1 | 2018 | 338 | 0.120 |
Why?
| | Receptors, Adrenergic, alpha | 1 | 2013 | 32 | 0.120 |
Why?
| | Cytochrome P-450 CYP3A Inhibitors | 1 | 2013 | 17 | 0.120 |
Why?
| | Proline | 1 | 2013 | 71 | 0.110 |
Why?
| | Nursing Staff | 2 | 2010 | 37 | 0.110 |
Why?
| | Hoarding | 1 | 2012 | 3 | 0.110 |
Why?
| | Respiratory Tract Infections | 1 | 2016 | 331 | 0.110 |
Why?
| | Program Evaluation | 1 | 2017 | 845 | 0.110 |
Why?
| | Electronic Health Records | 3 | 2014 | 829 | 0.110 |
Why?
| | Accidental Falls | 2 | 2016 | 154 | 0.110 |
Why?
| | Practice Patterns, Physicians' | 2 | 2011 | 1200 | 0.110 |
Why?
| | Assisted Living Facilities | 2 | 2016 | 10 | 0.110 |
Why?
| | Teaching | 1 | 2014 | 236 | 0.100 |
Why?
| | Kidney | 1 | 2019 | 1353 | 0.100 |
Why?
| | Education, Nursing, Continuing | 1 | 2011 | 40 | 0.100 |
Why?
| | Prognosis | 1 | 2019 | 3443 | 0.100 |
Why?
| | Stakeholder Participation | 2 | 2022 | 69 | 0.100 |
Why?
| | Interpersonal Relations | 1 | 2014 | 345 | 0.100 |
Why?
| | Adult | 8 | 2020 | 31512 | 0.100 |
Why?
| | Glucosamine | 1 | 2010 | 12 | 0.090 |
Why?
| | Administration, Inhalation | 1 | 2012 | 656 | 0.090 |
Why?
| | Chondroitin Sulfates | 1 | 2010 | 35 | 0.090 |
Why?
| | Anti-Anxiety Agents | 1 | 2010 | 38 | 0.090 |
Why?
| | Mass Screening | 3 | 2018 | 1052 | 0.090 |
Why?
| | Parathyroid Hormone | 2 | 2008 | 99 | 0.090 |
Why?
| | Piracetam | 1 | 2009 | 15 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2014 | 2174 | 0.090 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 95 | 0.090 |
Why?
| | Drug Administration Schedule | 1 | 2011 | 736 | 0.090 |
Why?
| | Infection Control | 1 | 2010 | 135 | 0.090 |
Why?
| | Stroke | 1 | 2018 | 1047 | 0.090 |
Why?
| | Delphi Technique | 1 | 2009 | 164 | 0.090 |
Why?
| | Hip Fractures | 1 | 2010 | 79 | 0.080 |
Why?
| | Immunization Programs | 1 | 2010 | 206 | 0.080 |
Why?
| | Drug Dosage Calculations | 1 | 2008 | 21 | 0.080 |
Why?
| | Conflict of Interest | 1 | 2009 | 120 | 0.080 |
Why?
| | Anticonvulsants | 1 | 2009 | 184 | 0.080 |
Why?
| | Surveys and Questionnaires | 4 | 2018 | 4708 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2011 | 693 | 0.080 |
Why?
| | Anxiety Disorders | 1 | 2010 | 309 | 0.070 |
Why?
| | Heptanoic Acids | 1 | 2007 | 62 | 0.070 |
Why?
| | Nutrition Policy | 1 | 2007 | 58 | 0.070 |
Why?
| | Decision Making | 2 | 2011 | 809 | 0.070 |
Why?
| | Phosphorus | 1 | 2007 | 84 | 0.070 |
Why?
| | Simvastatin | 1 | 2007 | 65 | 0.070 |
Why?
| | Orthodontics, Corrective | 1 | 2006 | 7 | 0.070 |
Why?
| | Inpatients | 1 | 2010 | 388 | 0.070 |
Why?
| | Comorbidity | 1 | 2011 | 1527 | 0.070 |
Why?
| | Premedication | 1 | 2006 | 40 | 0.070 |
Why?
| | Serum Albumin | 1 | 2007 | 146 | 0.070 |
Why?
| | Isoxazoles | 1 | 2006 | 56 | 0.070 |
Why?
| | Pyrroles | 1 | 2007 | 191 | 0.070 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2005 | 54 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2017 | 4552 | 0.070 |
Why?
| | Life Expectancy | 1 | 2005 | 52 | 0.070 |
Why?
| | Metabolic Clearance Rate | 1 | 2004 | 113 | 0.060 |
Why?
| | Caregivers | 1 | 2011 | 709 | 0.060 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2005 | 79 | 0.060 |
Why?
| | Medical Records Systems, Computerized | 1 | 2005 | 92 | 0.060 |
Why?
| | Onychomycosis | 1 | 2004 | 2 | 0.060 |
Why?
| | Influenza, Human | 1 | 2010 | 554 | 0.060 |
Why?
| | Bone Diseases, Metabolic | 1 | 2004 | 60 | 0.060 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2016 | 1185 | 0.060 |
Why?
| | Communication | 3 | 2016 | 761 | 0.060 |
Why?
| | Pain, Postoperative | 1 | 2006 | 211 | 0.060 |
Why?
| | Palliative Care | 1 | 2010 | 629 | 0.060 |
Why?
| | Heart Failure | 1 | 2017 | 1969 | 0.060 |
Why?
| | Outpatients | 1 | 2007 | 325 | 0.060 |
Why?
| | Hematologic Diseases | 1 | 2004 | 60 | 0.060 |
Why?
| | Quality of Life | 2 | 2023 | 2366 | 0.060 |
Why?
| | Patient Discharge | 2 | 2020 | 796 | 0.060 |
Why?
| | Rheumatic Diseases | 1 | 2004 | 49 | 0.060 |
Why?
| | Risk Factors | 2 | 2007 | 9000 | 0.060 |
Why?
| | Time Factors | 2 | 2011 | 6412 | 0.060 |
Why?
| | Venlafaxine Hydrochloride | 1 | 2002 | 12 | 0.050 |
Why?
| | Sulfonamides | 1 | 2006 | 445 | 0.050 |
Why?
| | Algorithms | 1 | 2010 | 1541 | 0.050 |
Why?
| | Data Collection | 1 | 2005 | 658 | 0.050 |
Why?
| | Menstruation | 1 | 2002 | 36 | 0.050 |
Why?
| | Health Care Costs | 1 | 2005 | 394 | 0.050 |
Why?
| | Child | 2 | 2023 | 19129 | 0.050 |
Why?
| | Pharmaceutical Services | 2 | 2016 | 79 | 0.050 |
Why?
| | Potentially Inappropriate Medication List | 1 | 2021 | 14 | 0.050 |
Why?
| | Hospitalization | 1 | 2010 | 1785 | 0.050 |
Why?
| | Liver Diseases | 1 | 2004 | 282 | 0.050 |
Why?
| | Calcium | 1 | 2007 | 1169 | 0.050 |
Why?
| | Nervous System Diseases | 1 | 2004 | 261 | 0.050 |
Why?
| | Adolescent | 4 | 2023 | 18480 | 0.050 |
Why?
| | Analgesics, Opioid | 1 | 2008 | 794 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2016 | 1945 | 0.050 |
Why?
| | Biomarkers | 1 | 2010 | 3588 | 0.040 |
Why?
| | Kidney Function Tests | 1 | 2019 | 164 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2004 | 969 | 0.040 |
Why?
| | Protons | 1 | 2019 | 79 | 0.040 |
Why?
| | Depressive Disorder | 1 | 2002 | 333 | 0.040 |
Why?
| | Anxiety | 2 | 2018 | 845 | 0.040 |
Why?
| | Healthcare Financing | 1 | 2018 | 5 | 0.040 |
Why?
| | Prospective Studies | 2 | 2007 | 6471 | 0.040 |
Why?
| | Guidelines as Topic | 2 | 2010 | 262 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2016 | 1687 | 0.040 |
Why?
| | Geriatric Assessment | 1 | 2018 | 185 | 0.040 |
Why?
| | Nephrology Nursing | 1 | 2016 | 5 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 2019 | 401 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2017 | 238 | 0.030 |
Why?
| | Glomerular Filtration Rate | 1 | 2019 | 683 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1419 | 0.030 |
Why?
| | Skilled Nursing Facilities | 1 | 2016 | 122 | 0.030 |
Why?
| | Patient Readmission | 1 | 2020 | 634 | 0.030 |
Why?
| | Education, Medical, Undergraduate | 1 | 2017 | 199 | 0.030 |
Why?
| | Neuropsychological Tests | 1 | 2018 | 1032 | 0.030 |
Why?
| | Obesity | 1 | 2007 | 2746 | 0.030 |
Why?
| | Sleep | 1 | 2019 | 660 | 0.030 |
Why?
| | Neoplasms | 1 | 2008 | 2179 | 0.030 |
Why?
| | Cardiomyopathies | 1 | 2017 | 299 | 0.030 |
Why?
| | Medicare | 1 | 2018 | 663 | 0.030 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 2013 | 60 | 0.030 |
Why?
| | Medical Audit | 1 | 2013 | 75 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2019 | 9342 | 0.030 |
Why?
| | Comprehension | 1 | 2014 | 163 | 0.030 |
Why?
| | Drug Evaluation | 1 | 2012 | 81 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2016 | 1384 | 0.030 |
Why?
| | Cardiovascular Diseases | 1 | 2004 | 1798 | 0.030 |
Why?
| | Educational Status | 1 | 2014 | 437 | 0.030 |
Why?
| | Drug Therapy, Computer-Assisted | 1 | 2011 | 10 | 0.030 |
Why?
| | Electronic Mail | 1 | 2011 | 55 | 0.020 |
Why?
| | Pharmacies | 1 | 2011 | 31 | 0.020 |
Why?
| | Personal Autonomy | 1 | 2011 | 41 | 0.020 |
Why?
| | Complementary Therapies | 1 | 2011 | 71 | 0.020 |
Why?
| | Decision Trees | 1 | 2010 | 83 | 0.020 |
Why?
| | Midwestern United States | 1 | 2010 | 38 | 0.020 |
Why?
| | Disclosure | 1 | 2011 | 102 | 0.020 |
Why?
| | Medical Informatics | 1 | 2011 | 102 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 2009 | 4596 | 0.020 |
Why?
| | Massage | 1 | 2010 | 44 | 0.020 |
Why?
| | Clinical Competence | 1 | 2016 | 951 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 10793 | 0.020 |
Why?
| | Epilepsies, Partial | 1 | 2009 | 28 | 0.020 |
Why?
| | Medication Errors | 1 | 2010 | 92 | 0.020 |
Why?
| | Hypoglycemia | 1 | 2014 | 400 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2020 | 1865 | 0.020 |
Why?
| | Child, Preschool | 1 | 2023 | 9491 | 0.020 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2011 | 245 | 0.020 |
Why?
| | Primary Health Care | 1 | 2018 | 1560 | 0.020 |
Why?
| | Self Administration | 1 | 2008 | 125 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2010 | 599 | 0.020 |
Why?
| | Administration, Cutaneous | 1 | 2008 | 119 | 0.020 |
Why?
| | Oxycodone | 1 | 2008 | 45 | 0.020 |
Why?
| | Fentanyl | 1 | 2008 | 70 | 0.020 |
Why?
| | Methadone | 1 | 2008 | 69 | 0.020 |
Why?
| | Pain Management | 1 | 2010 | 294 | 0.020 |
Why?
| | Delayed-Action Preparations | 1 | 2008 | 161 | 0.020 |
Why?
| | Morphine | 1 | 2008 | 134 | 0.020 |
Why?
| | Orthodontic Wires | 1 | 2006 | 5 | 0.020 |
Why?
| | Kidney Diseases | 1 | 2009 | 439 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2006 | 403 | 0.020 |
Why?
| | Pain Measurement | 1 | 2006 | 469 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1244 | 0.010 |
Why?
| | Sex Factors | 1 | 2006 | 1781 | 0.010 |
Why?
|
|
Linnebur's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|